Cannabis Business Times Quotes Havens on the Impact of FDA Warning Letters to Delta-8 Companies


FDA Warns Four Companies for Selling Unapproved Animal Drugs That Contain CBD

The agency said in its warning letters that the drugs, which are intended for use in food-producing animals, violate the Federal Food, Drug, and Cosmetic Act.

By Melissa Schiller

Jonathan Havens, co-chair of the Cannabis Law Practice and the Food and Beverage Practice at Saul Ewing, told Cannabis Business Times earlier this month, regarding the FDA’s warning to the delta-8 companies, that the warning letters serve to weed out bad actors in the cannabis and hemp industries.

“While this is not a good look for the industry, I do think that it will make the industry better in that it will shine a light on whose marketing practices are unsavory and whose are responsible,” he said. “I think there could be an upside here."

Read Full Article on Cannabis Business Times